Terms: = Uterine cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Treatment
20 results:
1. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial cancer Cells by Regulating the AKT/foxo1 Pathway.
Jiang J; Zhang C; Wang J; Zhu Y; Wang X; Mao P
Anticancer Agents Med Chem; 2023; 23(19):2127-2134. PubMed ID: 37670696
[TBL] [Abstract] [Full Text] [Related]
2. MiR-196a-5p facilitates progression of estrogen-dependent endometrial cancer by regulating foxo1.
Zhu Y; Tang Y; Fan Y; Wu D
Histol Histopathol; 2023 Oct; 38(10):1157-1168. PubMed ID: 36573636
[TBL] [Abstract] [Full Text] [Related]
3. Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/foxo1 axis.
Wang H; Shi H
Exp Biol Med (Maywood); 2021 Nov; 246(21):2307-2316. PubMed ID: 34233525
[TBL] [Abstract] [Full Text] [Related]
4. miR-96 enhances the proliferation of cervical cancer cells by targeting foxo1.
Yang L; Liu L; Zhang X; Zhu Y; Li L; Wang B; Liu Y; Ren C
Pathol Res Pract; 2020 Apr; 216(4):152854. PubMed ID: 32057517
[TBL] [Abstract] [Full Text] [Related]
5. Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids.
Omar M; Laknaur A; Al-Hendy A; Yang Q
BMC Womens Health; 2019 Jul; 19(1):92. PubMed ID: 31288815
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-9 enhances invasion and migration of cervical carcinomas by directly targeting foxo1.
Aishanjiang A; Rouzi N; Jiao Z; Wang L; Wusainahong K; Wumanjiang N; Musha M; Niyazi M
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2253-2260. PubMed ID: 29762826
[TBL] [Abstract] [Full Text] [Related]
7. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-foxo1 signal pathway.
Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
[TBL] [Abstract] [Full Text] [Related]
8. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract] [Full Text] [Related]
9. In silico, in vitro and in vivo analysis identifies a potential role for steroid hormone regulation of FOXD3 in endometriosis-associated genes.
Mathew D; Drury JA; Valentijn AJ; Vasieva O; Hapangama DK
Hum Reprod; 2016 Feb; 31(2):345-54. PubMed ID: 26705148
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of foxo1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
[TBL] [Abstract] [Full Text] [Related]
11. Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women.
Kataoka H; Mori T; Yamamoto T; Sawada M; Kuroboshi H; Tatsumi H; Iwasaku K; Kitawaki J
Eur J Gynaecol Oncol; 2014; 35(1):11-5. PubMed ID: 24654454
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic modification restores functional PR expression in endometrial cancer cells.
Yang S; Xiao X; Jia Y; Liu X; Zhang Y; Wang X; Winters CJ; Devor EJ; Meng X; Thiel KW; Leslie KK
Curr Pharm Des; 2014; 20(11):1874-80. PubMed ID: 23888956
[TBL] [Abstract] [Full Text] [Related]
13. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.
Neubauer NL; Ward EC; Patel P; Lu Z; Lee I; Blok LJ; Hanifi-Moghaddam P; Schink J; Kim JJ
Horm Cancer; 2011 Jun; 2(3):170-81. PubMed ID: 21760855
[TBL] [Abstract] [Full Text] [Related]
14. Involvement of fkhr (foxo1) transcription factor in human uterus leiomyoma growth.
Kovács KA; Lengyel F; Wilhelm F; Vértes Z; Sumegi B; Vértes M
Fertil Steril; 2010 Sep; 94(4):1491-1495. PubMed ID: 19772960
[TBL] [Abstract] [Full Text] [Related]
15. Progestins activate the AKT pathway in leiomyoma cells and promote survival.
Hoekstra AV; Sefton EC; Berry E; Lu Z; Hardt J; Marsh E; Yin P; Clardy J; Chakravarti D; Bulun S; Kim JJ
J Clin Endocrinol Metab; 2009 May; 94(5):1768-74. PubMed ID: 19240153
[TBL] [Abstract] [Full Text] [Related]
16. Induction of apoptosis in endometrial cancer cells by psammaplysene A involves foxo1.
Berry E; Hardt JL; Clardy J; Lurain JR; Kim JJ
Gynecol Oncol; 2009 Feb; 112(2):331-6. PubMed ID: 19041124
[TBL] [Abstract] [Full Text] [Related]
17. Chemosensitization of endometrial cancer cells through AKT inhibition involves foxo1.
Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
[TBL] [Abstract] [Full Text] [Related]
18. Mechanism and functional consequences of loss of foxo1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis.
Burney RO; Talbi S; Hamilton AE; Vo KC; Nyegaard M; Nezhat CR; Lessey BA; Giudice LC
Endocrinology; 2007 Aug; 148(8):3814-26. PubMed ID: 17510236
[TBL] [Abstract] [Full Text] [Related]
20. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract] [Full Text] [Related]
